Ÿ ] Shares1 Venaxis, Inc. Common Stock PURCHASE AGREEMENTPurchase Agreement • May 20th, 2013 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • New York
Venaxis, Inc., a Colorado corporation (the “Company”), proposes to sell to Piper Jaffray & Co. (the “Underwriter”) an aggregate of [ Ÿ ] shares (the “Firm Shares”) of Common Stock, no par value per share (the “Common Stock”), of the Company. The Firm Shares consist of [ Ÿ ] authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company has also granted to the Underwriter an option to purchase up to [ Ÿ ] additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
